These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men. Dubois EF; Derks MG; Schweitzer DH; Zwinderman AH; Dekhuijzen PN; van Boxtel CJ Eur J Clin Pharmacol; 2004 Jul; 60(5):315-28. PubMed ID: 15150679 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of prednisolone during administration of sirolimus in patients with renal transplants. Jusko WJ; Ferron GM; Mis SM; Kahan BD; Zimmerman JJ J Clin Pharmacol; 1996 Dec; 36(12):1100-6. PubMed ID: 9013365 [TBL] [Abstract][Full Text] [Related]
8. Effects of oral and inhaled corticosteroid on lymphocyte beta2-adrenoceptor function in asthmatic patients. Tan KS; McFarlane LC; Lipworth BJ Br J Clin Pharmacol; 1997 Dec; 44(6):565-8. PubMed ID: 9431832 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of mycophenolate mofetil and sirolimus in children. Filler G; Bendrick-Peart J; Christians U Ther Drug Monit; 2008 Apr; 30(2):138-42. PubMed ID: 18367972 [TBL] [Abstract][Full Text] [Related]
10. Lack of pharmacokinetic and pharmacodynamic interactions between ketoconazole and prednisolone. Yamashita SK; Ludwig EA; Middleton E; Jusko WJ Clin Pharmacol Ther; 1991 May; 49(5):558-70. PubMed ID: 1827622 [TBL] [Abstract][Full Text] [Related]
11. Prednisolone- and sirolimus-eluting stent: Anti-inflammatory approach for inhibiting in-stent restenosis. Lee SY; Bae IH; Sung Park D; Jang EJ; Shim JW; Lim KS; Park JK; Sim DS; Jeong MH J Biomater Appl; 2016 Jul; 31(1):36-44. PubMed ID: 26873634 [TBL] [Abstract][Full Text] [Related]
12. Th1, Th2, Th17 cell subsets in two different immunosuppressive protocols in renal allograft recipients (Sirolimus vs mycophenolate mofetil): A cohort study. Eteghadi A; Pak F; Ahmadpoor P; Jamali S; Karimi M; Yekaninejad MS; Kokhaei P; Nafar M; Amirzargar AA Int Immunopharmacol; 2019 Feb; 67():319-325. PubMed ID: 30576916 [TBL] [Abstract][Full Text] [Related]
14. Concomitant administration of low-dose prednisolone protects against in vivo beta2-adrenoceptor subsensitivity induced by regular formoterol. Tan KS; McFarlane LC; Lipworth BJ Chest; 1998 Jan; 113(1):34-41. PubMed ID: 9440565 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic interactions between dehydroepiandrosterone and prednisolone in the rat. Meno-Tetang GM; Hon YY; Van Wart S; Jusko WJ Drug Metabol Drug Interact; 1999; 15(1):51-70. PubMed ID: 10707113 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction between single oral doses of diltiazem and sirolimus in healthy volunteers. Böttiger Y; Säwe J; Brattström C; Tollemar J; Burke JT; Häss G; Zimmerman JJ Clin Pharmacol Ther; 2001 Jan; 69(1):32-40. PubMed ID: 11180036 [TBL] [Abstract][Full Text] [Related]
17. Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus. Park SI; Felipe CR; Pinheiro-Machado PG; Garcia R; Fernandes FB; Casarini DE; Tedesco-Silva H; Medina-Pestana JO Fundam Clin Pharmacol; 2009 Feb; 23(1):137-45. PubMed ID: 19267777 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic/pharmacodynamic evaluation of deflazacort in comparison to methylprednisolone and prednisolone. Möllmann H; Hochhaus G; Rohatagi S; Barth J; Derendorf H Pharm Res; 1995 Jul; 12(7):1096-100. PubMed ID: 7494809 [TBL] [Abstract][Full Text] [Related]
20. L-Carnitine ester of prednisolone: pharmacokinetic and pharmacodynamic evaluation of a type I prodrug. Mo J; Lim LY; Zhang ZR Int J Pharm; 2014 Nov; 475(1-2):123-9. PubMed ID: 25173636 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]